此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Identifying the Effect and Working Mechanisms of MyPlan 2.0 in Older Adults

2021年12月3日 更新者:University Ghent

A Randomized Controlled Trial to Identify the Effect and the Working Mechanisms of MyPlan 2.0, a Self-regulation-based e- and mHealth Intervention Targeting Physical Activity and Sedentary Behaviour, in Older Adults

The aim of this study is to investigate whether and how 'MyPlan 2.0' helps older adults to be more physically active or less sedentary. Two groups will be created, an intervention group and a waiting-list control group.

研究概览

详细说明

The aim of this study is to investigate whether and how 'MyPlan 2.0' helps older adults to be more physically active or less sedentary. Two groups will be created, an intervention group and a waiting-list control group. Both groups will be tested during three testing waves: pretest, posttest and follow-up test. Only the intervention group will be given acces to 'MyPlan 2.0'.

'MyPlan 2.0' consists of a website and mobile application targeting physical activity and sedentary behaviour. The intervention has a duration of five weeks.

研究类型

介入性

注册 (实际的)

63

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Ghent、比利时、9000
        • Department of Movement and Sports Sciences

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

50年 及以上 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Have access to internet
  • Being computer literate

Exclusion Criteria:

  • non Dutch speaking

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:干预组
参与者将接受电子和移动医疗干预“MyPlan 2.0”。
MyPlan 2.0 由五个部分组成。 在这五个环节中,使用以下行为改变技术来激励用户进行更多的身体活动或减少久坐:探索风险认知和认知收益、探索社会支持、提供反馈、行动计划、应对计划和监测。
实验性的:Waiting List control group
Participants will not receive the e- and mHealth intervention 'MyPlan 2.0', but will be given access to the intervention after all testing phases.
Waiting List control group

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
目标总体、轻度和中度至剧烈体力活动 (PA) 的变化
大体时间:前测、后测(6 周)和跟进(6 个月)
通过加速度计测量的总体、轻度和中度至剧烈身体活动量的变化
前测、后测(6 周)和跟进(6 个月)
客观久坐行为的改变
大体时间:前测、后测(6 周)和跟进(6 个月)
总坐着时间的变化,通过加速度计测量
前测、后测(6 周)和跟进(6 个月)
Change in self-reported total, moderate and moderate-to-vigorous physical activity (PA) as well as total work-related, transport-related, household-related and leisure time PA.
大体时间:Pretest, posttest (6 weeks) and follow-up (6 months)
Change in amount of total, light and moderate-to-vigorous PA well as total work-related, transport-related, household-related and leisure time PA will be measured via the International Physical Activity Questionnaire (IPAQ). The IPAQ measures physical activity in four domains: work, transport, household and leisure time. Higher scores indicate higher levels of physical activity. For each scale the minimum value is 0. We will use the method described by Dubuy et al. (2013) to truncate the data.
Pretest, posttest (6 weeks) and follow-up (6 months)
Change in self-reported sedentary behaviour
大体时间:Pretest, posttest (6 weeks) and follow-up (6 months)
Change in amount of total sitting time, measured via the LASA sedentary behaviour self-report questionnaire. The total score is calculated by summing all 10 items.The minimum value is 0 and the maximum value is 24 hours. However, data will be truncated at 16 hours.
Pretest, posttest (6 weeks) and follow-up (6 months)

次要结果测量

结果测量
措施说明
大体时间
Change in self-efficacy
大体时间:Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months)
Change in amount of self-efficacy to change behaviour, measured via 5 validated items (questionnaire). These items were created by the involved research groups. For each item, the scale ranges from 1 to 10. The average score on the five items will be considered the final score.
Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months)
Change in outcome expectancies
大体时间:Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months
Outcome expectancies regarding the behaviour change, measured via 5 validated items (questionnaire). These items were created by the involved research groups. For each item, the scale ranges from 1 to 10. The average score on the five items will be considered the final score.
Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months
Change in risk perception
大体时间:Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months
Risk perception about the behaviour, measured via 4 validated items (questionnaire). These items were created by the involved research groups. For each item, the scale ranges from 1 to 10. The average score on the four items will be considered the final score
Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months
Change in intention
大体时间:Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months
Amount of intention to change the behaviour, measured via 3 validated items (questionnaire). These items were created by the involved research groups. For each item, the scale ranges from 1 to 10. The average score on the three items will be considered the final score.
Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months
Change in action planning
大体时间:Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months
Amount of action planning for behaviour change, measured via 3 validated items (questionnaire). These items were created by the involved research groups. For each item, the scale ranges from 1 to 10. The average score on the three items will be considered the final score.
Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months
Change in coping planning
大体时间:Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months
Amount of coping planning for behaviour change, measured via 3 validated items (questionnaire). These items were created by the involved research groups. For each item, the scale ranges from 1 to 10. The average score on the three items will be considered the final score.
Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Ilse De Bourdeaudhuij、University Ghent
  • 首席研究员:Geert Crombez、University Ghent

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2018年1月15日

初级完成 (实际的)

2018年8月15日

研究完成 (实际的)

2019年4月15日

研究注册日期

首次提交

2019年1月7日

首先提交符合 QC 标准的

2019年1月9日

首次发布 (实际的)

2019年1月10日

研究记录更新

最后更新发布 (实际的)

2021年12月6日

上次提交的符合 QC 标准的更新

2021年12月3日

最后验证

2021年12月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • MyPlan2.0_older_adults_50

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅